TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common stock, $0.0001 par value
Symbol
TLSI on Nasdaq
Shares outstanding
49,883,741
Price per share
$6.98
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,563,230
Total reported value
$44,470,060
% of total 13F portfolios
0%
Share change
+1,091,367
Value change
+$5,042,569
Number of holders
54
Price from insider filings
$6.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Frankenius Equity AB 14% -31% $34,179,868 +$1,257,864 6,989,748 +3.8% Frankenius Equity AB 31 Jul 2025
Utmost Group Plc 6.8% $15,741,343 +$6,438,609 3,385,235 +69% Utmost Group PLC 30 Sep 2025
Wahlstrom Mats 6% -33% $14,610,738 +$931,271 2,987,881 +6.8% Mats Wahlstrom 31 Jul 2025
Nantahala Capital Management, LLC 4.1% -24% $9,487,139 +$187,139 2,040,245 +2% Nantahala Capital Management, LLC 30 Sep 2025

As of 30 Sep 2025, 54 institutional investors reported holding 9,563,230 shares of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI). This represents 19% of the company’s total 49,883,741 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 4.1% 2,040,245 +2% 0.59% $9,487,139
AWM Investment Company, Inc. 2.5% 1,250,000 0% 0.54% $5,812,500
VANGUARD GROUP INC 2.3% 1,159,575 +42% 0% $5,392,024
GILDER GAGNON HOWE & CO LLC 2.1% 1,047,059 -4.2% 0.05% $4,868,824
BlackRock, Inc. 1.6% 787,864 +27% 0% $3,663,568
Wealthcare Advisory Partners LLC 1.3% 643,740 0% 0.06% $2,993,391
Alyeska Investment Group, L.P. 1.1% 557,500 0% 0.01% $2,592,375
GEODE CAPITAL MANAGEMENT, LLC 1.1% 554,455 +22% 0% $2,578,591
STATE STREET CORP 0.39% 192,633 +67% 0% $895,743
BANK OF AMERICA CORP /DE/ 0.38% 189,180 +0.15% 0% $879,687
NORTHERN TRUST CORP 0.35% 176,654 +40% 0% $821,441
GOLDMAN SACHS GROUP INC 0.3% 150,487 +795% 0% $699,765
Corient Private Wealth LLC 0.15% 75,700 0% $352,005
Squarepoint Ops LLC 0.15% 73,706 0% $342,733
CWA Asset Management Group, LLC 0.14% 72,000 0.01% $334,800
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.14% 69,500 -7.8% 0.01% $323,175
WHITE PINE CAPITAL LLC 0.12% 59,733 0.08% $277,758
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.11% 57,305 +15% 0% $266,468
Bank of New York Mellon Corp 0.09% 46,704 +12% 0% $217,172
MSD Partners, L.P. 0.08% 39,999 0% 0.12% $185,995
MILLENNIUM MANAGEMENT LLC 0.07% 35,612 +18% 0% $165,596
Connective Capital Management, LLC 0.07% 32,796 0% 0.14% $152,501
BARCLAYS PLC 0.05% 26,468 -12% 0% $123,076
Vestcor Inc 0.05% 23,376 0% 0% $109,000
Connecticut Wealth Management, LLC 0.04% 22,303 0% 0% $103,709

Institutional Holders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 715,899 $4,996,975 +$412 $6.98 5
2025 Q3 9,563,230 $44,470,060 +$5,042,569 $4.65 54
2025 Q2 8,470,104 $46,161,422 +$30,072,898 $5.45 46
2025 Q1 2,947,768 $16,271,736 +$3,567,159 $5.52 33
2024 Q4 2,345,660 $11,752,144 +$904,681 $5.01 28
2024 Q3 2,171,190 $10,009,408 +$2,041,090 $4.61 31
2024 Q2 1,617,489 $8,929,169 +$3,605,411 $5.52 26
2024 Q1 925,707 $9,026,910 +$2,616,406 $9.75 24
2023 Q4 679,602 $5,741,892 +$4,363,853 $8.45 19
2023 Q3 136,575 $699,263 +$699,263 $5.12 9